Cargando…

Etiology, Clinical Presentations, and Short-Term Treatment Outcomes of Extrahepatic Obstructive Jaundice in South-Western Uganda

BACKGROUND: The diagnosis of extrahepatic obstructive jaundice (EHOJ) remains a challenge and is often made late in low-resource settings. Systematic data are limited on the etiology and prognosis of patients with obstructive jaundice in Uganda. The objective of this study was to determine the etiol...

Descripción completa

Detalles Bibliográficos
Autores principales: Odongo, Charles Newton, Dreque, Carlos Cabrera, Mutiibwa, David, Bongomin, Felix, Oyania, Felix, Sikhondze, Mvuyo Maqhawe, Acan, Moses, Atwine, Raymond, Kirya, Fred, Situma, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199528/
https://www.ncbi.nlm.nih.gov/pubmed/35721671
http://dx.doi.org/10.2147/CEG.S356977
_version_ 1784727858569019392
author Odongo, Charles Newton
Dreque, Carlos Cabrera
Mutiibwa, David
Bongomin, Felix
Oyania, Felix
Sikhondze, Mvuyo Maqhawe
Acan, Moses
Atwine, Raymond
Kirya, Fred
Situma, Martin
author_facet Odongo, Charles Newton
Dreque, Carlos Cabrera
Mutiibwa, David
Bongomin, Felix
Oyania, Felix
Sikhondze, Mvuyo Maqhawe
Acan, Moses
Atwine, Raymond
Kirya, Fred
Situma, Martin
author_sort Odongo, Charles Newton
collection PubMed
description BACKGROUND: The diagnosis of extrahepatic obstructive jaundice (EHOJ) remains a challenge and is often made late in low-resource settings. Systematic data are limited on the etiology and prognosis of patients with obstructive jaundice in Uganda. The objective of this study was to determine the etiology, clinical presentations, and short-term treatment outcomes of patients managed for EHOJ at Mbarara Regional Referral Hospital (MRRH) in south-western Uganda. METHODS: Between September 2019 and May 2020, we prospectively enrolled a cohort of patients who presented with EHOJ at MRRH. A pretested, semi-structured data collection tool was used to abstract data from both the study participants and their files. RESULTS: A total of 72 patients, 42 (58.3%) of whom were male with a median age of 56 (range of 2 months to 95 years) were studied. Forty-two (58.3%) participants had malignancies: Pancreatic head tumors 20 (27.8%), cholangiocarcinoma 13 (18.1%), duodenal cancers 5 (6.94%), and gall bladder cancer 4 (5.6%). The remaining 30 (41.7%) participants had benign etiologies: choledocholithiasis 10 (13.9%), biliary atresia 7 (9.7%), pancreatic pseudo cyst 6 (8.3%), Mirizzi syndrome 5 (6.9%) and 1 (1.4%) each of chronic pancreatitis and choledochal cyst. Sixty-seven (93.1%) patients presented with right upper quadrant tenderness, 65 (90.3%) abdominal pain and 55 (76.3%) clay-colored stool. Cholecystectomy 11 (25.6%) and cholecystojejunostomy + jejunojejunostomy 8 (18.6%) were the commonest procedures performed. Twelve (17.0%) of cases received chemotherapy (epirubicin/cisplatin/capecitabine) for pancreatic head tumors and (gemcitabine/oxaliplatine) for cholangiocarcinoma. Mortality rate was 29.2% in the study, of which malignancy carried the highest mortality 20 (95.24%). CONCLUSION: Malignancy was the main cause of EHOJ observed in more than half of the patients. Interventions aimed at early recognition and appropriate referral are key in this population to improve outcomes.
format Online
Article
Text
id pubmed-9199528
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-91995282022-06-16 Etiology, Clinical Presentations, and Short-Term Treatment Outcomes of Extrahepatic Obstructive Jaundice in South-Western Uganda Odongo, Charles Newton Dreque, Carlos Cabrera Mutiibwa, David Bongomin, Felix Oyania, Felix Sikhondze, Mvuyo Maqhawe Acan, Moses Atwine, Raymond Kirya, Fred Situma, Martin Clin Exp Gastroenterol Original Research BACKGROUND: The diagnosis of extrahepatic obstructive jaundice (EHOJ) remains a challenge and is often made late in low-resource settings. Systematic data are limited on the etiology and prognosis of patients with obstructive jaundice in Uganda. The objective of this study was to determine the etiology, clinical presentations, and short-term treatment outcomes of patients managed for EHOJ at Mbarara Regional Referral Hospital (MRRH) in south-western Uganda. METHODS: Between September 2019 and May 2020, we prospectively enrolled a cohort of patients who presented with EHOJ at MRRH. A pretested, semi-structured data collection tool was used to abstract data from both the study participants and their files. RESULTS: A total of 72 patients, 42 (58.3%) of whom were male with a median age of 56 (range of 2 months to 95 years) were studied. Forty-two (58.3%) participants had malignancies: Pancreatic head tumors 20 (27.8%), cholangiocarcinoma 13 (18.1%), duodenal cancers 5 (6.94%), and gall bladder cancer 4 (5.6%). The remaining 30 (41.7%) participants had benign etiologies: choledocholithiasis 10 (13.9%), biliary atresia 7 (9.7%), pancreatic pseudo cyst 6 (8.3%), Mirizzi syndrome 5 (6.9%) and 1 (1.4%) each of chronic pancreatitis and choledochal cyst. Sixty-seven (93.1%) patients presented with right upper quadrant tenderness, 65 (90.3%) abdominal pain and 55 (76.3%) clay-colored stool. Cholecystectomy 11 (25.6%) and cholecystojejunostomy + jejunojejunostomy 8 (18.6%) were the commonest procedures performed. Twelve (17.0%) of cases received chemotherapy (epirubicin/cisplatin/capecitabine) for pancreatic head tumors and (gemcitabine/oxaliplatine) for cholangiocarcinoma. Mortality rate was 29.2% in the study, of which malignancy carried the highest mortality 20 (95.24%). CONCLUSION: Malignancy was the main cause of EHOJ observed in more than half of the patients. Interventions aimed at early recognition and appropriate referral are key in this population to improve outcomes. Dove 2022-06-11 /pmc/articles/PMC9199528/ /pubmed/35721671 http://dx.doi.org/10.2147/CEG.S356977 Text en © 2022 Odongo et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Odongo, Charles Newton
Dreque, Carlos Cabrera
Mutiibwa, David
Bongomin, Felix
Oyania, Felix
Sikhondze, Mvuyo Maqhawe
Acan, Moses
Atwine, Raymond
Kirya, Fred
Situma, Martin
Etiology, Clinical Presentations, and Short-Term Treatment Outcomes of Extrahepatic Obstructive Jaundice in South-Western Uganda
title Etiology, Clinical Presentations, and Short-Term Treatment Outcomes of Extrahepatic Obstructive Jaundice in South-Western Uganda
title_full Etiology, Clinical Presentations, and Short-Term Treatment Outcomes of Extrahepatic Obstructive Jaundice in South-Western Uganda
title_fullStr Etiology, Clinical Presentations, and Short-Term Treatment Outcomes of Extrahepatic Obstructive Jaundice in South-Western Uganda
title_full_unstemmed Etiology, Clinical Presentations, and Short-Term Treatment Outcomes of Extrahepatic Obstructive Jaundice in South-Western Uganda
title_short Etiology, Clinical Presentations, and Short-Term Treatment Outcomes of Extrahepatic Obstructive Jaundice in South-Western Uganda
title_sort etiology, clinical presentations, and short-term treatment outcomes of extrahepatic obstructive jaundice in south-western uganda
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199528/
https://www.ncbi.nlm.nih.gov/pubmed/35721671
http://dx.doi.org/10.2147/CEG.S356977
work_keys_str_mv AT odongocharlesnewton etiologyclinicalpresentationsandshorttermtreatmentoutcomesofextrahepaticobstructivejaundiceinsouthwesternuganda
AT drequecarloscabrera etiologyclinicalpresentationsandshorttermtreatmentoutcomesofextrahepaticobstructivejaundiceinsouthwesternuganda
AT mutiibwadavid etiologyclinicalpresentationsandshorttermtreatmentoutcomesofextrahepaticobstructivejaundiceinsouthwesternuganda
AT bongominfelix etiologyclinicalpresentationsandshorttermtreatmentoutcomesofextrahepaticobstructivejaundiceinsouthwesternuganda
AT oyaniafelix etiologyclinicalpresentationsandshorttermtreatmentoutcomesofextrahepaticobstructivejaundiceinsouthwesternuganda
AT sikhondzemvuyomaqhawe etiologyclinicalpresentationsandshorttermtreatmentoutcomesofextrahepaticobstructivejaundiceinsouthwesternuganda
AT acanmoses etiologyclinicalpresentationsandshorttermtreatmentoutcomesofextrahepaticobstructivejaundiceinsouthwesternuganda
AT atwineraymond etiologyclinicalpresentationsandshorttermtreatmentoutcomesofextrahepaticobstructivejaundiceinsouthwesternuganda
AT kiryafred etiologyclinicalpresentationsandshorttermtreatmentoutcomesofextrahepaticobstructivejaundiceinsouthwesternuganda
AT situmamartin etiologyclinicalpresentationsandshorttermtreatmentoutcomesofextrahepaticobstructivejaundiceinsouthwesternuganda